Standard BioTools Inc. Operating Leases, Future Minimum Payments Due, Next Twelve Months
Standard BioTools Inc. (LAB) had Operating Leases, Future Minimum Payments Due, Next Twelve Months of $4.18 million as of 2018-12-31, per its 10-K filed 2020-02-27.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent · last filed 2020-02-27
- 2018-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $4.18M.
- 2017-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $4.24M.
- 2016-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $4.29M.
- 2015-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $4.08M.
| Period end | Operating Leases, Future Minimum Payments Due, Next Twelve Months |
|---|---|
| 2018-12-31 | $4.18M 10-K · filed 2020-02-27 |
| 2017-12-31 | $4.24M 10-K · filed 2018-03-08 |
| 2016-12-31 | $4.29M 10-K · filed 2017-03-03 |
| 2015-12-31 | $4.08M 10-K · filed 2016-02-29 |
| 2014-12-31 | $3.15M 10-K · filed 2015-02-26 |
| 2013-12-31 | $2.08M 10-K · filed 2014-03-12 |
| 2012-12-31 | $1.48M 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |